answer text |
<p>The National Institute for Health and Care Excellence (NICE) does not currently
recommend any specific treatment for Alpha-1 Antitrypsin Deficiency (AATD).</p><p>
</p><p>NHS England is engaging with NICE on the Highly Specialised Technologies evaluation
of human alpha1-proteinase inhibitor for treating emphysema in adults with documented
severe AATD (ID856). NICE has not yet published final guidance and recently consulted
on its draft guidance.</p><p> </p><p>NICE’s evaluation committee is due to meet again
to consider its recommendations in due course.</p>
|
|